UPC CFI 616/2025
Nov 6, 2025·EP2590626 · LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY
- Case details
- StatusDeliberation PhaseActionInfringementCategoryMain infringement action
- Parties
- Claimants
- GlaxoSmithKline Biologicals SAOperating co.
Representatives- Tjibbe Douma-Bird & Bird LLP
- Carlos van Staveren-Bird & Bird LLP
- Nicole Jadeja-Bird & Bird LLP
- Emilia Zalewska-Bird & Bird LLP
Respondents- Moderna Netherlands B.V.Operating co.
- Moderna Biotech Spain SLOperating co.
- Moderna Biotech UK LimitedOperating co.
- Moderna Biotech Distributor UK LtdOperating co.
- Moderna Switzerland GmbHOperating co.
- Moderna Poland Sp. z o.o.Operating co.
- Moderna, Inc.Operating co.
- ModernaTX, Inc.Operating co.
- Moderna Belgium S.R.L.Operating co.
- Moderna France SASUOperating co.
- Moderna Germany GmbHOperating co.
- Moderna Italy S.R.L.Operating co.
- Moderna Portugal Unipessoal LDAOperating co.
- Moderna Sweden ABOperating co.
- Moderna Norway ASOperating co.
Representatives- Gertjan Kuipers-Hogan Lovells Cadwalader International LLP
- Thomas Wolter-Mewburn Ellis LLP
- Andreas von Falck-Hogan Lovells Cadwalader International LLP
- Lukas Sievers-Hogan Lovells Cadwalader International LLP
- Floris Patijn-Hogan Lovells Cadwalader International LLP
- Division
- The Hague LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- First decided
- Feb 18, 2026
- Last decision
- Sep 14, 2026
- EPO Opposition
- Dennemeyer & Associates S.A.Withdrawn2016-07-28
| Infringement found | Median days to first decision | |
|---|---|---|
| All UPC | 53% (62/117) | 124 |
| The Hague LD | Locked | Locked |
| Judge Edger Brinkman | Locked | Locked |
| Judge Margot Kokke | Locked | Locked |
| Judge Stefan Schilling | Locked | Locked |
| Judge Martin Schmidt | Locked | Locked |
At the UPC: GlaxoSmithKline Biologicals SA (20 cases)·Moderna Group (20 cases)
This dispute contains 1 other proceedings
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2025
- 2026-09-14InfringementPublic
Summary: The Hague Local Division panel order (11 Sep 2026) in GlaxoSmithKline Biologicals SA v Moderna Netherlands B.V. and fourteen Moderna affiliates (EP 2 590 626; infringement action UPC_CFI_616/2025 and counterclaim for revocation UPC_CFI_1439/2025): after the oral hearing of 1 Sep 2026, the panel revokes under R. 335 RoP the judge-rapporteur's earlier rejection of GSK's late-filed 'New ATEM' cryo-TEM reports with stained RNA of the accused products, admits them, orders GSK to resubmit them with a 600-word explanation by 16 Sep 2026 and lets Moderna respond within one week; the target decision date is unaffected.
Show the legal issues (3)
- Revocation of a judge-rapporteur's case management order by the panel (R. 331.3, 334, 335 RoP)
- Admission of late-filed evidence after the oral hearing; right to be heard (Art. 76(2) UPCA)
- R. 114 RoP exceptional case
- 2026-02-18Infringement ActionPublic
Summary: The Hague Local Division ruled on GSK's application to amend its claim under Rule 263 RoP and Moderna's application to dismiss late-filed submissions under Rule 9 RoP in patent infringement proceedings relating to mRNA vaccine technology.
Show the legal issues (3)
- Amendment of claim Rule 263 RoP
- Late-filed submissions Rule 9 RoP
- mRNA vaccine patent
| Document title | Date | Public |
|---|---|---|
| Communication | 2026-10-08 | Not public |
| Deliberation opened | 2026-10-08 | Not public |
| Receipt | 2026-09-23 | Not public |
| Cover sheet | 2026-09-23 | Not public |
| Document Defendant | 2026-09-23 | Not public |
| Receipt | 2026-09-16 | Not public |
| Cover sheet | 2026-09-16 | Not public |
| Exhibit Claimant | 2026-09-16 | Not public |
| Exhibit Claimant | 2026-09-16 | Not public |
| Exhibit Claimant | 2026-09-16 | Not public |